Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-001315-31-SE
EUCTR2007-001315-31-SE
Active, not recruiting
Not Applicable

Double-blind, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules versus placebo for maintenance of remission in patients with collagenous colitis - SOIBD Collagenous Colitis Maintenance Study (SCCMS)

Dr. Falk Pharma GmbH0 sites110 target enrollmentFebruary 12, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsBudenofalk 3 mg

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr. Falk Pharma GmbH
Enrollment
110
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Patients aged \>\= 18 years,
  • •\- Histologically established diagnosis of collagenous colitis (CC) defined as:
  • •a) Thickened sub\-epithelial collagen layer \>\= 10 µm on well\-orientated sections
  • •b) Increased amount of inflammatory cells indicating chronic inflammation in the
  • •lamina propria
  • •\- History of non\-bloody, watery diarrhoea for more than 2 weeks prior screening in
  • •patients with nexly diagnosed collagenous colitis, or history of clinical relapse for
  • •more than 1 week prior screening in patients with previously established
  • •collagenous colitis
  • •\- A mean of \>\= 3 stools/day, thereof a mean of \>\= 1 watery stolls/day, during the

Exclusion Criteria

  • •\- Other significant abnormalities at colonoscopy that may have been the cause
  • •of diarrhoea, with the exception of colonic diverticulosis and polyps \< 2 cm
  • •\- Infectious cause of diarrhoea
  • •\- Untreated active celiac disease
  • •\- Clinical suspicion of drug\-induced collagenous colitis
  • •\- Any severe concomitant cardiovascular, renal, endocrine, or psychiatric disorder
  • •\- Abnormal hepatic function (ALT or ALP \> 2\.5 x upper limit of normal ULN), liver
  • •cirrhosis, or portal hypertension
  • •\- Local intestinal infection
  • •\- Radiation therapy towards the abdominal or pelvic region

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Study to evaluate the effectiveness and safety of 3 doses of embryonated eggs of the porcine whipworm compared to placebo (dummy drug) in the treatment of active Crohn's disease.
EUCTR2006-000720-13-DEDr. Falk Pharma GmbH400
Active, not recruiting
Phase 1
Double-blinded, randomised, placebo-controlled, multicentre , Phase IIa study to investigate the effect efficacy, safety and tolerability of phosphorylcholine human monoclonal antibody (PC-mAb) 3G10 on arterial inflammation, together with safety and tolerability, in subjects with elevated lipoprotein a (Lp[a ])Arterial inflammation in subjects with elevated lipoprotein a (Lp[a])MedDRA version: 20.0Level: LLTClassification code 10051615Term: Atherosclerotic cardiovascular diseaseSystem Organ Class: 100000022953Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-002106-13-SEAthera Biotechnologies AB40
Active, not recruiting
Phase 1
Double-blind, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules versus placebo for maintenance of remission in patients with collagenous colitis - SOIBD Collagenous Colitis Maintenance Study (SCCMS)Collagenous colitisMedDRA version: 8.1 Level: LLT Classification code 10048928 Term: Colitis collagenous
EUCTR2007-001315-31-BEDr. Falk Pharma GmbH92
Active, not recruiting
Not Applicable
Double-blind, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules versus placebo for maintenance of remission in patients with collagenous colitis - SOIBD Collagenous Colitis Maintenance Study (SCCMS)Collagenous colitisMedDRA version: 13.1Level: PTClassification code 10048928Term: Colitis collagenousSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2007-001315-31-DKDr. Falk Pharma GmbH110
Active, not recruiting
Not Applicable
Study to evaluate the effectiveness and safety of 3 doses ofembryonated eggs of the porcine whipworm compared to placebo(dummy drug) in the treatment of active Crohn's disease.
EUCTR2006-000720-13-CZDr. Falk Pharma GmbH400